What tests are used to diagnose intestinal helminth infections?

Testing for Intestinal Worms

The primary diagnostic approach combines concentrated stool microscopy (using formalin-ether concentration technique) with Strongyloides serology, and for specific clinical scenarios, molecular testing (PCR) provides superior sensitivity. 1

Core Diagnostic Strategy

First-Line Testing

Stool microscopy remains the foundation of diagnosis, but the method matters significantly:

• Formalin-Ether Concentration Technique (FECT) is superior to simple stool smears 2

  • Detects hookworm, Trichuris trichiura, and small liver flukes more effectively than crude formalin methods
  • More sensitive than single Kato-Katz thick smears for most helminths 3
  • Critical caveat: Has lower sensitivity for Strongyloides compared to other soil-transmitted helminths 1

• Multiple stool samples improve detection: Single specimens miss infections, particularly in low-intensity cases

Essential Adjunct Testing

Strongyloides serology must be added routinely 1:

• Concentrated stool microscopy has poor sensitivity for Strongyloides
• High prevalence found in asymptomatic migrants with eosinophilia
• Missing this diagnosis has severe consequences (hyperinfection risk with immunosuppression)

Species-Specific Considerations

Different helminths require tailored approaches:

For Schistosomiasis:

• Terminal urine microscopy for S. haematobium (look for eggs in urine, especially terminal stream)
• Stool microscopy for S. mansoni and other intestinal species
• Serology is valuable, particularly in acute Katayama syndrome when egg production hasn't started (2-8 weeks post-exposure) 1
• Kato-Katz detects S. mansoni more effectively than FECT 3

For Strongyloides:

• Serology is more sensitive than stool microscopy 1
• FECT detects it significantly better than Kato-Katz when present (OR = 5.02) 3

For common soil-transmitted helminths (Ascaris, hookworm, Trichuris):

• FECT performs well for all three 2
• Kato-Katz thick smear is acceptable alternative, particularly for moderate-to-high intensity infections 3

Advanced Diagnostic Methods

Molecular Testing (PCR)

qPCR demonstrates superior sensitivity but isn't routinely necessary 4, 5:

• Detects as low as 5 eggs per gram (EPG) versus 50 EPG for microscopy 5
• Strong correlation with egg counts for Trichuris (0.86-0.87) and Ascaris (0.60-0.63) 4
• Best reserved for: low-prevalence settings, treatment efficacy monitoring, or when microscopy is repeatedly negative despite high clinical suspicion 5

Supporting Laboratory Tests

Peripheral eosinophilia is a key diagnostic clue:

• Often markedly elevated (>5 × 10⁹/L) in acute schistosomiasis 1
• Present in many helminth infections, though can be absent
• Helps prioritize helminth testing in appropriate clinical contexts

Practical Algorithm

1. Obtain travel/exposure history: freshwater exposure (schistosomiasis), soil contact, walking barefoot (hookworm), wild game consumption (trichinosis) 6

2. Check complete blood count: look for eosinophilia

3. Order stool testing:

   • Formalin-ether concentration technique on 2-3 specimens
   • Always add Strongyloides serology 1

4. For schistosomiasis suspicion:

   • Add schistosoma serology
   • Terminal urine microscopy if S. haematobium suspected
   • Consider empirical treatment if acute Katayama syndrome (fever, rash, eosinophilia 2-8 weeks after freshwater exposure) 1

5. If microscopy negative but suspicion high:

   • Consider PCR testing 5
   • Repeat stool samples
   • Re-evaluate serology results

Critical Pitfalls to Avoid

• Don't rely on single stool sample: sensitivity is inadequate
• Don't skip Strongyloides serology: stool microscopy misses most cases 1
• Don't use simple wet mount alone: concentration techniques are essential 2
• Don't assume negative stool rules out schistosomiasis in acute infection: serology needed 1
• Don't forget urine examination for S. haematobium: stool won't show it

The diagnostic approach must match the clinical context—returning travelers with eosinophilia warrant broader testing including serology, while endemic populations may justify empirical treatment when testing is negative but exposure history is compelling 1.